Thanks for your comments, doc.
I've sold other biotechs in the past, only to watch its share price climb 10x's or more a year or two later.
While ONVO isn't a true biotech, the liver tox assay they now sell to biotechs will be a necessary component of many biotechs and research companies, etc. going forward. Let alone other things ONVO has in its pipeline.
I'm sticking with ONVO for a long, long time. They'll have to pry my shares from my dead, cold hands in order to get them.
Sounds a little bit what happened to my several years ago, reilly. Weierd things were happening to many investors in the stock I was in then, so many investors (incl me) made up new aliases to even begin posting again.
My original alias was "stck_guy", which I couldn't use anymore for some reason. (I think the problem is resolved now though.) Anyway, I set up "profiteer" (think modern buccaneer... lol) which I have been using ever since then.
Juggsy: Our baby will be common knowledge soon enough in investor circles.
I think the downturn would have been less severe if Keith would have been more open about contract specifics. IMO, the analysts are punishing him for that.
Although the entire market seems a bit skittish lately, perhaps this remark was made by a big-time short on the FOX show. Or the big time money is rotating from the biotech sector to something else... I doubt that, but still have to think about it.
Hopefully, next week will bring some clarity and calm to the market, and investors, big and small, will rush in to snap up beaten down stocks -- including ONVO.
Agreed. Keith and company are going places I do believe. And, we as longs, are going to benefit quite nicely.
wchurch: It lessens the chance of failure, but doesn't eliminate it. That's why some investors wait for one or more quarters of financials before adding to their positions.